CYNTHIA TREVINO: Open Payments
NPI 1497836761 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 11 payments from 8 companies in 2025. Trend: 2023 $222 · 2024 $449 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $235 |
| Syndax Pharmaceuticals, Inc. | 2 | $152 |
| SOBI, INC | 2 | $146 |
| Incyte Corporation | 1 | $126 |
| Janssen Biotech, Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
| Astellas Pharma US Inc | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $32 |
Products named: REZUROCK, Vonjo, Niktimvo, REVUFORJ, RYBREVANT, LIVTENCITY, Cresemba, OJJAARA.
Industry payments across TX — which companies pay providers there.
